| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/22/2006 | EP1635819A1 Staurosporine derivatives for hypereosinophilic syndrome |
| 03/22/2006 | EP1635817A1 1-phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor xa inhibitors for the treatment of acute vascular diseases |
| 03/22/2006 | EP1635689A2 Method and kit for controlling bleeding |
| 03/22/2006 | EP1412357B1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/22/2006 | EP1301516B1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/22/2006 | EP1272488B1 Tri-aryl-substituted-ethane pde4 inhibitors |
| 03/22/2006 | CN1748784A Process for producing ampeptide element |
| 03/22/2006 | CN1748762A Jinshu leaf styptic mixture and its preparing method and use |
| 03/22/2006 | CN1748757A Dragon's blood external use preparation and its preparing method |
| 03/22/2006 | CN1748745A Chinese medicine granular powder for tonifying blood and regulating menstruation, arresting bleeding and miscarriage prevention and its preparing method |
| 03/22/2006 | CN1748722A Chinese medicine composition for treating cardio-cerebral vascular diseases and its preparing method and use |
| 03/22/2006 | CN1246462C Modified vitamin K-dependent polypeptides |
| 03/22/2006 | CN1246047C A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 03/22/2006 | CN1246037C Novel use of serum beta 2-glucoprotein I functional peptide segment for preparing thrombolytic medicine |
| 03/22/2006 | CN1246011C Use of lotus root joint extract in preparing medicine for improving human insulin resistance and preventing obesity |
| 03/22/2006 | CN1245991C Shark meat extract |
| 03/21/2006 | US7015311 That binds to a neurturin polypeptide of given sequences that promotes survival of superior cervical ganglion cells or nodose ganglion cells; can be used to detect and monitor patient levels of neurturin |
| 03/21/2006 | US7015246 Benzofuran derivatives |
| 03/21/2006 | US7015231 such as (3Z)-3-[(1-methyl-1H-indol-3-yl)methylene]-1,3-dihydro-2H-pyrrolo[3,2-b]pyridin-2-one; tyrosine kinase inhibitors; for treatment of tumor growth, restenosis, atherosclerosis, pain and thrombosis |
| 03/21/2006 | US7015230 serine protease inhibitors comprising pyrimidinediones, used as anticoagulants for prophylaxis of cardiovascular disorders; thrombolytic agents |
| 03/21/2006 | US7015223 Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade |
| 03/21/2006 | US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases |
| 03/21/2006 | US7015217 Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 03/21/2006 | US7014847 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 03/21/2006 | CA2270887C Methods and compositions for inhibition of angiogenesis |
| 03/21/2006 | CA2263983C Cyclic amine derivatives for inhibiting blood platelet aggregation |
| 03/21/2006 | CA2154080C Novel anticoagulant cofactor activity |
| 03/21/2006 | CA2072416C Cyclopropenone derivatives |
| 03/21/2006 | CA1341502C Method for the production of erythropoietin |
| 03/16/2006 | WO2006028122A1 Agent for preventing and ameliorating obesity |
| 03/16/2006 | WO2006027130A1 Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds |
| 03/16/2006 | US20060058389 Novel compounds that inhibit factor xa activity |
| 03/16/2006 | US20060058346 Novel enantiomers of etrahydroisoquinoline derivatives and theirpharmaceutically acceptable salts, their preparations and pharmaceutical compositions |
| 03/16/2006 | US20060058345 Use of papaverine-like vasodilator and pharmaceutical composition |
| 03/16/2006 | US20060058304 Azaindole kinase inhibitors |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058291 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 03/16/2006 | US20060058288 Severe sepsis preventive therapeutic agent |
| 03/16/2006 | US20060058253 Methods to reprogram splice site selection in pre-messenger rnas |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 03/16/2006 | US20060057156 Materials and methods for inductions of immune tolerance |
| 03/16/2006 | CA2580132A1 Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds |
| 03/16/2006 | CA2578958A1 Acetylated starch or starch succinate for treatment of obesity or diabetes |
| 03/15/2006 | EP1634596A1 Aporphine and oxoaporphine and the medical use thereof |
| 03/15/2006 | EP1634081A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 03/15/2006 | EP1633769A1 Novel transcription factor, bp1 |
| 03/15/2006 | EP1633746A1 New indole derivatives as factor xa inhibitors |
| 03/15/2006 | EP1633745A1 Aroyl semicarbazide derivatives against thromboembolic diseases |
| 03/15/2006 | EP1633716A2 Biarylmethyl indolines, indoles and tetrahydroquinolines, useful as serine protease inhibitors |
| 03/15/2006 | EP1633440A1 Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles |
| 03/15/2006 | EP1633347A1 2-pyrrolidone derivatives and use thereof as factor xa inhibitors |
| 03/15/2006 | EP1633346A1 Pyrrolidin-1, 2- dicarboxylic acid- 1- (4- ethinyl- phenyl) - amid]- 2- (phenyl)- amid] derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis |
| 03/15/2006 | EP1633333A1 Use of hif alpha stabilizers for enhancing erythropoiesis |
| 03/15/2006 | EP1465864B1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/15/2006 | EP1435908A4 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof |
| 03/15/2006 | EP1408962B1 Substituted isoindoles and the use thereof |
| 03/15/2006 | EP1379244A4 1,4,5,6-tetrahydropyrazolo- 3,4-c]-pyridin-7-ones as factor xa inhibitors |
| 03/15/2006 | EP1342730B1 Fusion protein having the enhanced in vivo activity of erythropoietin |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1309589B1 Urea compounds and methods of uses |
| 03/15/2006 | EP1289992B1 New crystalline form of a triazolo(4,5-d)pyrimidine compound |
| 03/15/2006 | EP1129078B1 Indazole derivatives with 5-ht2 receptor activity |
| 03/15/2006 | EP1128842B1 Use of human protein c for the manufacture of a medicament for treating heparin-induced thrombocytopenia |
| 03/15/2006 | EP0892849B1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 03/15/2006 | EP0804438B1 Tricyclic benzazepine vasopressin antagonists |
| 03/15/2006 | CN1747967A Peptide conjugate |
| 03/15/2006 | CN1747734A Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders |
| 03/15/2006 | CN1747732A 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 03/15/2006 | CN1746182A Design of antisuppository KGD-cyclohepta-peptide, its preparation and use thereof |
| 03/15/2006 | CN1745749A Likejun capsule and production thereof |
| 03/15/2006 | CN1245405C Piperazine derivatives |
| 03/15/2006 | CN1245391C Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors |
| 03/15/2006 | CN1245381C Phenylglycine derivatives |
| 03/15/2006 | CN1245376C Substituted 2-dialkylamino alkylbiphenyl derivatives |
| 03/15/2006 | CN1245216C Stabilized liquid polypeptide-containing. pharmaceutical compositions |
| 03/15/2006 | CN1245179C Hematinic agent of blood tonic |
| 03/15/2006 | CN1245172C Uses ofroot of Co donopsis Pilosula-astragalus composition in treating ischemic heart disease |
| 03/15/2006 | CN1245167C Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 03/14/2006 | US7012132 Modified factor VIII |
| 03/14/2006 | US7012099 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 03/14/2006 | US7012095 Compounds for modulating cell proliferation |
| 03/14/2006 | US7012084 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 03/14/2006 | US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders |
| 03/14/2006 | US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 03/14/2006 | US7011855 Biochemically balanced peritoneal dialysis solutions |
| 03/14/2006 | US7011825 Erythropoietin solution preparation |
| 03/14/2006 | CA2375430C C-pyrazole a2a receptor agonists |
| 03/14/2006 | CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/14/2006 | CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 03/14/2006 | CA2214070C Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 03/14/2006 | CA2051494C 1-aryl-3-pyridinyl-2-propene-1-ones as calcium uptake inhibitors |
| 03/14/2006 | CA1341501C Vectors for the expression and segregation of hirudine by transformed yeasts |
| 03/09/2006 | WO2006024241A1 Preparation comprising ionic iron and haem iron and variants thereof for the prophylaxis and treatment of iron deficiency |
| 03/09/2006 | US20060052606 Factor xa Inhibitors |
| 03/09/2006 | US20060052455 Composition for preventing treating the xepression of clinical symptom in disease caused by mitochondrial dysfunction |
| 03/09/2006 | US20060052389 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 03/09/2006 | US20060052376 Carboxamides |
| 03/09/2006 | US20060052332 1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-carboxamides; adenosine receptors (A2A); for stimulating mammalian coronary vasodilatation for therapy and imaging the heart |
| 03/09/2006 | US20060052323 Method to inhibit cell growth using oligonucleotides |
| 03/09/2006 | US20060052314 Pharmaceutical combination |